ESR1 and breast cancer: It was suggested that inflammatory mediators, secreted by adversely-activated Mφ, may upregulate expression of aromatase by stromal cells of “obese” adipose tissue, leading to an increase in estrogen levels, and, thus, selectively promoting ER+ BC in obese postmenopausal patients [13,18,41,42].